IVD Product Market, Global Scenario, Market Size, Outlook, Trend and Forecast 2018-2026
The Global In-Vitro Diagnostics (IVD) Product Market is expected to reach $94.5 Billion by 2026; with a CAGR of 4.9 % from 2019 to 2026. Asia-Pacific is the fastest growing market in the IVD product. The growing numbers of chronic & infectious diseases along with the rising number of age-old population in the world boost the market in the estimated period.
The key market drivers in the global IVD market are the increasing investment in the research & development, application of that research in the unexplored areas along with the increasing awareness in the adoption of IVD in multiple disease ailments are expected to boost the market. However, the stringent norms by the government and less support from the regulatory agencies may hamper the market. The cost –effectiveness of the diagnostic solution & further increasing awareness in global IVD Market projects the tremendous potential in the coming years.
The global IVD product market is segmented into product, application, end-use, technology, and geography. By application, the market is divided into cardiac, gene engineering, immune system disorders and others. By end-use, the market is divided into academic & medical research, pharmaceuticals, and others. By product, the market is further divided into software & services, reagents, instruments & others. By technology, the market is divided into clinical research, hematology, immunodiagnostic and others. The global IVD market is distributed across the several geographical regions such as North America, Europe, Asia-Pacific, and Rest of the World (RoW).
The country-wise analysis has been also covered under the scope of the report. North America covers the U.S., Canada, and Mexico while Europe covers Germany, France, Italy, UK, & Rest of Europe. Japan, China, Russia, India, South Korea, Australia, and Rest of Asia-Pacific have been analyzed under the Asia-Pacific market. Rest of the world includes Central & South America, the Middle East, and Africa.
The scope of the report covers in-depth analysis of the market in terms of both qualitative and quantitative analysis across the segments as well as cross-sectional analysis of the segments including the geographies and its countries. The market has been analyzed both from demand as well as supply side to come to an accurate scenario. Products across application and application across geographies have been mapped to provide you a precise competitive scenario to have a leading edge in the market.
Key companies operating in this market and their company profile along with the market share analysis and competitive scenario is also part of the report. Top players are Qiagen N.V., Becton, Dickinson and Company, Bio-Rad Laboratories, Abbott Laboratories, Hoffmann-La Roche AG, Sysmex Corporation, Thermo Fischer Scientific, Danaher Corporation, Siemens Healthcare GmbH, Ortho-Clinical Diagnostics and others.
The Highlights of the Report
Scope of the Global IVD Market
• North America
o South Korea
o Rest of Asia-Pacifi
o Rest of Europe
• Rest of the World
• Central & South America
• The Middle East